Caption Management, LLC
Position in XERS — Xeris Biopharma Holdings, Inc.
CIK 1706766
OKLAHOMA CITY, OK
Position in XERS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,189,000
+$1,189,000 QoQ
Shares Held
205,000
Ownership
0.119%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in XERS Over Time
Shares Held
Position Value (USD)
Derivatives in XERS
reported options exposure · as of Mar 31, 2026CallValue
$2,339,720
CallShares
403,400
PutValue
$2,572,300
PutShares
443,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Caption Management, LLC holds $68,208,344 across 11 Drug Manufacturers - Specialty & Generic names. XERS ranks #4 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
74,445 | $44,144,396 | |
| 2 | ANIP |
Ani Pharmaceuticals Inc
|
135,890 | $10,449,941 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
280,058 | $8,435,346 | |
| 4 | XERS |
Xeris Biopharma Holdings, Inc.
This page
|
205,000 | $1,189,000 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
8,900 | $1,172,486 | |
| 6 | CRON |
Cronos Group Inc.
|
371,061 | $931,363 | |
| 7 | EOLS |
Evolus, Inc.
|
216,316 | $889,058 | |
| 8 | PRGO |
PERRIGO Co plc
|
44,000 | $472,560 |
All Filings in XERS
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,339,720 | 403,400 | Call | Sole | 2026-05-15 | |
| 2026-03-31 | $1,189,000 | 205,000 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $2,572,300 | 443,500 | Put | Sole | 2026-05-15 | |
| 2025-12-31 | $968,690 | 123,400 | Call | Sole | 2026-02-17 | |
| 2023-12-31 | $104,340 | 44,400 | Call | Sole | 2024-02-14 | |
| 2023-09-30 | $82,584 | 44,400 | Call | Sole | 2023-11-14 | |
| 2023-06-30 | $116,328 | 44,400 | Call | Sole | 2023-08-14 | |
| 2021-12-31 | $139,468 | 47,600 | Shares | Sole | 2022-02-11 | |
| 2021-12-31 | $139,468 | 47,600 | Put | Sole | 2022-02-11 | |
| No filing history on record for this holder in this stock. | ||||||